The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study

IntroductionMurine tumor growth restriction by neem leaf glycoprotein (NLGP) was established in various transplanted models of murine sarcoma, melanoma and carcinoma. However, the role of NLGP in the sequential carcinogenic steps has not been explored. Thus, tongue carcinogenesis in Swiss mice was i...

Full description

Saved in:
Bibliographic Details
Main Authors: Juhina Das, Saurav Bera, Nilanjan Ganguly, Ipsita Guha, Tithi Ghosh Halder, Avishek Bhuniya, Partha Nandi, Mohona Chakravarti, Sukanya Dhar, Anirban Sarkar, Tapasi Das, Saptak Banerjee, Sandip Ghose, Anamika Bose, Rathindranath Baral
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1325161/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846164245232746496
author Juhina Das
Saurav Bera
Nilanjan Ganguly
Ipsita Guha
Tithi Ghosh Halder
Avishek Bhuniya
Partha Nandi
Mohona Chakravarti
Sukanya Dhar
Anirban Sarkar
Tapasi Das
Saptak Banerjee
Sandip Ghose
Anamika Bose
Anamika Bose
Rathindranath Baral
author_facet Juhina Das
Saurav Bera
Nilanjan Ganguly
Ipsita Guha
Tithi Ghosh Halder
Avishek Bhuniya
Partha Nandi
Mohona Chakravarti
Sukanya Dhar
Anirban Sarkar
Tapasi Das
Saptak Banerjee
Sandip Ghose
Anamika Bose
Anamika Bose
Rathindranath Baral
author_sort Juhina Das
collection DOAJ
description IntroductionMurine tumor growth restriction by neem leaf glycoprotein (NLGP) was established in various transplanted models of murine sarcoma, melanoma and carcinoma. However, the role of NLGP in the sequential carcinogenic steps has not been explored. Thus, tongue carcinogenesis in Swiss mice was induced by 4-nitroquinoline-1-oxide (4NQO), which has close resemblance to human carcinogenesis process. Interventional role of NLGP in initiation-promotion protocol established during 4NQO mediated tongue carcinogenesis in relation to systemic immune alteration and epithelial-mesenchymal transition (EMT) is investigated.Methods4NQO was painted on tongue of Swiss mice every third day at a dose of 25µl of 5mg/ml stock solution. After three consecutive treatments with 4NQO (starting Day7), one group of mice was treated with NLGP (s.c. 25μg/mice/week), keeping a group as PBS control. Mice were sacrificed in different time-intervals to harvest tongues and studied using histology, immunohistochemistry, flow-cytometry and RT-PCR on different immune cells and EMT markers (e-cadherin, vimentin) to elucidate their phenotypic and secretory status.ResultsLocal administration of 4NQO for consecutive 300 days promotes significant alteration in tongue mucosa including erosion in papillae and migration of malignant epithelial cells to the underlying connective tissue stroma with the formation of cell nests (exophytic-hyperkeratosis with mild dysplasia). Therapeutic NLGP treatment delayed pre-neoplastic changes promoting normalization of mucosa by maintaining normal structure. Flow-cytometric evidences suggest that NLGP treatment upregulated CD8+, IFNγ+, granzyme B+, CD11c+ cells in comparison to 4NQO treated mice with a decrease in Ki67+ and CD4+FoxP3+ cells in NLGP treated cohort. RT-PCR demonstrated a marked reduction of MMP9, IL-6, IL-2, CD31 and an upregulation in CCR5 in tongues from 4NQO+NLGP treated mice in comparison to 4NQO treated group. Moreover, 4NQO mediated changes were associated with reduction of e-cadherin and simultaneous up-regulation of vimentin expression in epithelium that was partially reversed by NLGP.DiscussionEfficacy of NLGP was tested first time in sequential carcinogenesis model and proved effective in delaying the initial progression. NLGP normalizes type 1 immunity including activation of the CD8+T effector functions, reduction of regulatory T cell functions, along with changes in EMT to make the host systemically alert to combat the carcinogenic threat.
format Article
id doaj-art-135df3f8dc1c4a1a8b7e8e4a38eabc10
institution Kabale University
issn 1664-3224
language English
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-135df3f8dc1c4a1a8b7e8e4a38eabc102024-11-18T10:58:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-03-011510.3389/fimmu.2024.13251611325161The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical studyJuhina Das0Saurav Bera1Nilanjan Ganguly2Ipsita Guha3Tithi Ghosh Halder4Avishek Bhuniya5Partha Nandi6Mohona Chakravarti7Sukanya Dhar8Anirban Sarkar9Tapasi Das10Saptak Banerjee11Sandip Ghose12Anamika Bose13Anamika Bose14Rathindranath Baral15Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Oral Pathology, Dr. R. Ahmed Dental College and Hospital, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Pharmaceutical Technology (Biotechnology), National Institute of Pharmaceutical Education and Research (NIPER), Sahibzada Ajit Singh Nagar, Punjab, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaIntroductionMurine tumor growth restriction by neem leaf glycoprotein (NLGP) was established in various transplanted models of murine sarcoma, melanoma and carcinoma. However, the role of NLGP in the sequential carcinogenic steps has not been explored. Thus, tongue carcinogenesis in Swiss mice was induced by 4-nitroquinoline-1-oxide (4NQO), which has close resemblance to human carcinogenesis process. Interventional role of NLGP in initiation-promotion protocol established during 4NQO mediated tongue carcinogenesis in relation to systemic immune alteration and epithelial-mesenchymal transition (EMT) is investigated.Methods4NQO was painted on tongue of Swiss mice every third day at a dose of 25µl of 5mg/ml stock solution. After three consecutive treatments with 4NQO (starting Day7), one group of mice was treated with NLGP (s.c. 25μg/mice/week), keeping a group as PBS control. Mice were sacrificed in different time-intervals to harvest tongues and studied using histology, immunohistochemistry, flow-cytometry and RT-PCR on different immune cells and EMT markers (e-cadherin, vimentin) to elucidate their phenotypic and secretory status.ResultsLocal administration of 4NQO for consecutive 300 days promotes significant alteration in tongue mucosa including erosion in papillae and migration of malignant epithelial cells to the underlying connective tissue stroma with the formation of cell nests (exophytic-hyperkeratosis with mild dysplasia). Therapeutic NLGP treatment delayed pre-neoplastic changes promoting normalization of mucosa by maintaining normal structure. Flow-cytometric evidences suggest that NLGP treatment upregulated CD8+, IFNγ+, granzyme B+, CD11c+ cells in comparison to 4NQO treated mice with a decrease in Ki67+ and CD4+FoxP3+ cells in NLGP treated cohort. RT-PCR demonstrated a marked reduction of MMP9, IL-6, IL-2, CD31 and an upregulation in CCR5 in tongues from 4NQO+NLGP treated mice in comparison to 4NQO treated group. Moreover, 4NQO mediated changes were associated with reduction of e-cadherin and simultaneous up-regulation of vimentin expression in epithelium that was partially reversed by NLGP.DiscussionEfficacy of NLGP was tested first time in sequential carcinogenesis model and proved effective in delaying the initial progression. NLGP normalizes type 1 immunity including activation of the CD8+T effector functions, reduction of regulatory T cell functions, along with changes in EMT to make the host systemically alert to combat the carcinogenic threat.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1325161/full4NQOCD8+ T cellsimmunotherapeuticsneem leaf glycoproteinNotch1oral carcinogenesis
spellingShingle Juhina Das
Saurav Bera
Nilanjan Ganguly
Ipsita Guha
Tithi Ghosh Halder
Avishek Bhuniya
Partha Nandi
Mohona Chakravarti
Sukanya Dhar
Anirban Sarkar
Tapasi Das
Saptak Banerjee
Sandip Ghose
Anamika Bose
Anamika Bose
Rathindranath Baral
The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study
Frontiers in Immunology
4NQO
CD8+ T cells
immunotherapeutics
neem leaf glycoprotein
Notch1
oral carcinogenesis
title The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study
title_full The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study
title_fullStr The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study
title_full_unstemmed The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study
title_short The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study
title_sort immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4nqo induced murine oral carcinogenesis a preclinical study
topic 4NQO
CD8+ T cells
immunotherapeutics
neem leaf glycoprotein
Notch1
oral carcinogenesis
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1325161/full
work_keys_str_mv AT juhinadas theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT sauravbera theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT nilanjanganguly theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT ipsitaguha theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT tithighoshhalder theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT avishekbhuniya theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT parthanandi theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT mohonachakravarti theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT sukanyadhar theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT anirbansarkar theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT tapasidas theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT saptakbanerjee theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT sandipghose theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT anamikabose theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT anamikabose theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT rathindranathbaral theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT juhinadas immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT sauravbera immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT nilanjanganguly immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT ipsitaguha immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT tithighoshhalder immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT avishekbhuniya immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT parthanandi immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT mohonachakravarti immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT sukanyadhar immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT anirbansarkar immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT tapasidas immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT saptakbanerjee immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT sandipghose immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT anamikabose immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT anamikabose immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy
AT rathindranathbaral immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy